P+P Pöllath + Partners
P+P Pöllath + Partners advised CABB Management on the acquisition by Bridgepoint from AXA Private Equity
P+P Pöllath + Partners / Key word(s): Legal Matter P+P Pöllath + Partners advised CABB Management on the acquisition by Bridgepoint from AXA Private Equity Frankfurt, 16 March 2011 CABB, a global provider of fine and specialty chemicals, has been acquired by Bridgepoint from AXA Private Equity. The company is based in Sulzbach near Frankfurt and generated a turnover of EUR311 million in 2010. CABB is one of the world's leading suppliers of chemical building blocks based on chlorine and acetic acid and the world market leader in monochloroacetic acid (MCAA), an essential component used in a wide range of applications ranging from herbicides, personal care to the food industry. It is also a leading custom manufacturer for global agrochemical, food, pharma and chemical companies. The former part of the Hoechst group currently operates four manufacturing sites, two of them in Germany. P+P Pöllath + Partners were mandated by CABB and advised by Dr. Jan Wildberger in the Frankfurt office and Dr. Benedikt Hohaus in the Munich office.
Advisors CABB
Dr. Jan Wildberger (corporate), Frankfurt
Press Contact: End of financial news 16.03.2011 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
115643 16.03.2011 |